Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase - PubMed (original) (raw)
Comparative Study
doi: 10.1093/carcin/bgh165. Epub 2004 Apr 8.
Affiliations
- PMID: 15073046
- DOI: 10.1093/carcin/bgh165
Comparative Study
Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase
Jungil Hong et al. Carcinogenesis. 2004 Sep.
Abstract
Aberrant arachidonic acid metabolism is involved in the inflammatory and carcinogenic processes. In this study, we investigated the effects of curcumin, a naturally occurring chemopreventive agent, and related beta-diketone derivatives on the release of arachidonic acid and its metabolites in the murine macrophage RAW264.7 cells and in HT-29 human colon cancer cells. We also examined their effects on the catalytic activities and protein levels of related enzymes: cytosolic phospholipase A(2) (cPLA(2)), cyclooxygenases (COX) as well as 5-lipoxygenase (5-LOX). At 10 micro M, dibenzoylmethane (DBM), trimethoxydibenzoylmethane (TDM), tetrahydrocurcumin (THC) and curcumin effectively inhibited the release of arachidonic acid and its metabolites in lipopolysaccharide (LPS)-stimulated RAW cells and A23187-stimulated HT-29 cells. Inhibition of phosphorylation of cPLA(2), the activation process of this enzyme, rather than direct inhibition of cPLA(2) activity appears to be involved in the effect of curcumin. All the curcuminoids (10 micro M) potently inhibited the formation of prostaglandin E(2) (PGE(2)) in LPS-stimulated RAW cells. Curcumin (20 micro M) significantly inhibited LPS-induced COX-2 expression; this effect, rather than the catalytic inhibition of COX, may contribute to the decreased PGE(2) formation. Without LPS-stimulation, however, curcumin increased the COX-2 level in the macrophage cells. Studies with isolated ovine COX-1 and COX-2 enzymes showed that the curcuminoids had significantly higher inhibitory effects on the peroxidase activity of COX-1 than that of COX-2. Curcumin and THC potently inhibited the activity of human recombinant 5-LOX, showing estimated IC(50) values of 0.7 and 3 micro M, respectively. The results suggest that curcumin affects arachidonic acid metabolism by blocking the phosphorylation of cPLA(2), decreasing the expression of COX-2 and inhibiting the catalytic activities of 5-LOX. These activities may contribute to the anti-inflammatory and anticarcinogenic actions of curcumin and its analogs.
Similar articles
- Cytoplasmic phospholipase A2 levels correlate with apoptosis in human colon tumorigenesis.
Dong M, Johnson M, Rezaie A, Ilsley JN, Nakanishi M, Sanders MM, Forouhar F, Levine J, Montrose DC, Giardina C, Rosenberg DW. Dong M, et al. Clin Cancer Res. 2005 Mar 15;11(6):2265-71. doi: 10.1158/1078-0432.CCR-04-1079. Clin Cancer Res. 2005. PMID: 15788676 - Modulation of arachidonic acid metabolism and nitric oxide synthesis by garcinol and its derivatives.
Hong J, Sang S, Park HJ, Kwon SJ, Suh N, Huang MT, Ho CT, Yang CS. Hong J, et al. Carcinogenesis. 2006 Feb;27(2):278-86. doi: 10.1093/carcin/bgi208. Epub 2005 Aug 10. Carcinogenesis. 2006. PMID: 16093250 - Regulation of COX and LOX by curcumin.
Rao CV. Rao CV. Adv Exp Med Biol. 2007;595:213-26. doi: 10.1007/978-0-387-46401-5_9. Adv Exp Med Biol. 2007. PMID: 17569213 Review. - Bioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen species.
Cho KJ, Seo JM, Kim JH. Cho KJ, et al. Mol Cells. 2011 Jul;32(1):1-5. doi: 10.1007/s10059-011-1021-7. Epub 2011 Mar 18. Mol Cells. 2011. PMID: 21424583 Free PMC article. Review.
Cited by
- The Antioxidant Potential of Vitamins and Their Implication in Metabolic Abnormalities.
Theodosis-Nobelos P, Rekka EA. Theodosis-Nobelos P, et al. Nutrients. 2024 Aug 16;16(16):2740. doi: 10.3390/nu16162740. Nutrients. 2024. PMID: 39203876 Free PMC article. Review. - Pharmaceutical Potential of Remedial Plants and Helminths for Treating Inflammatory Bowel Disease.
Jamtsho T, Loukas A, Wangchuk P. Jamtsho T, et al. Pharmaceuticals (Basel). 2024 Jun 21;17(7):819. doi: 10.3390/ph17070819. Pharmaceuticals (Basel). 2024. PMID: 39065669 Free PMC article. Review. - Inflammation and cancer: friend or foe?
Turizo-Smith AD, Córdoba-Hernandez S, Mejía-Guarnizo LV, Monroy-Camacho PS, Rodríguez-García JA. Turizo-Smith AD, et al. Front Pharmacol. 2024 May 10;15:1385479. doi: 10.3389/fphar.2024.1385479. eCollection 2024. Front Pharmacol. 2024. PMID: 38799159 Free PMC article. Review. - Potential Alzheimer's early biomarkers in a transgenic rat model and benefits of diazoxide/dibenzoylmethane co-treatment on spatial memory and AD-pathology.
Wallace CH, Oliveros G, Xie L, Serrano P, Rockwell P, Figueiredo-Pereira M. Wallace CH, et al. Sci Rep. 2024 Feb 14;14(1):3730. doi: 10.1038/s41598-024-54156-z. Sci Rep. 2024. PMID: 38355687 Free PMC article. - Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases.
Xiang Y, Song X, Long D. Xiang Y, et al. Arch Toxicol. 2024 Mar;98(3):579-615. doi: 10.1007/s00204-023-03660-8. Epub 2024 Jan 24. Arch Toxicol. 2024. PMID: 38265475 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials